1. Clinical & Scientific Overview
Fusidic Acid, Nadifloxacin & Ketoconazole Topical Preparations (Dermatological Anti-Infectives) (TIP-MED-000238, Reference Code [12.6]) is classified under
Dermatological & Topical Antiseptic Preparations (Ch 12) as a Topical Corticosteroids (Grouped by Potency: Super-Potent Clobetasol, Potent Mometasone/Betamethasone, Mild Hydrocortisone), Topical Imidazole/Allylamine Antifungals (Luliconazole, Clotrimazole, Sertaconazole, Terbinafine, Ketoconazole), Topical Antibacterials (Mupirocin, Fusidic Acid), and Ectoparasiticides (Permethrin 5%).
Within the Indian regulatory and compendial framework, it is governed under Schedule H Prescription Drug (To be sold by retail on the prescription of a Registered Medical Practitioner only — Drugs Rules 1945).
Representative Indian Market Examples (Edition 2.7 Ch 12 [12.6], p. 157): • Topical Corticosteroids: Super-Potent (Class I): Clobetasol Propionate 0.05% (Tenovate, Lobate, Topinate); Halobetasol 0.05% (Halovate). Potent (Class II–III): Mometasone Furoate 0.1% (Momate, Elocon); Betamethasone Valerate/Dipropionate 0.05%–0.1% (Betnovate, Diprovate); Fluticasone 0.05% (Flutivate). Low-Potency (Class VI–VII—Face/Intertriginous/Paediatric): Desonide 0.05% (Desowen); Hydrocortisone Acetate 1% (Wycort). • Pure Topical Antifungals (Tinea/Candidiasis): Luliconazole 1% (Lulifin, Lulican—OD); Clotrimazole 1% (Candid Cream/Dusting Powder); Amorolfine/Sertaconazole/Eberconazole/Terbinafine 1% (Sebifin, Tyza); Ketoconazole 2% Shampoo (Nizral, Scalpe). • Topical Antibacterials (Impetigo/Folliculitis): Mupirocin 2% (T-Bact [GSK], Bactroban); Fusidic Acid 2% (Fudic, Fusiwal). — Strengths & Dosage Forms: Creams (water-miscible base for weeping/acute/intertriginous lesions), Ointments (occlusive greasy base for dry, thick, lichenified plaques on palms/soles/extensors), Lotions/Solutions (for hairy scalp)
Creams (water-miscible base for weeping/acute/intertriginous lesions), Ointments (occlusive greasy base for dry, thick, lichenified plaques on palms/soles/extensors), Lotions/Solutions (for hairy scalp)
3. Mechanism of Action & Pharmacodynamics
Topical Corticosteroids (Grouped by Potency: Super-Potent Clobetasol, Potent Mometasone/Betamethasone, Mild Hydrocortisone), Topical Imidazole/Allylamine Antifungals (Luliconazole, Clotrimazole, Sertaconazole, Terbinafine, Ketoconazole), Topical Antibacterials (Mupirocin, Fusidic Acid), and Ectoparasiticides (Permethrin 5%) acting on target receptor/enzyme pathways in Dermatological & Topical Antiseptic Preparations (Ch 12): clinical efficacy is mediated via Topical Corticosteroids (Grouped by Potency: Super-Potent Clobetasol, Potent Mometasone/Betamethasone, Mild Hydrocortisone), Topical Imidazole/Allylamine Antifungals (Luliconazole, Clotrimazole, Sertaconazole, Terbinafine, Ketoconazole), Topical Antibacterials (Mupirocin, Fusidic Acid), and Ectoparasiticides (Permethrin 5%) for • Topical Corticosteroids: Eczema / atopic dermatitis, contact dermatitis, plaque psoriasis, lichen planus, seborrhoeic dermatitis. • Pure Topical Antifungals: Dermatophytosis (Tinea corporis, Tinea cruris [dhobi itch], Tinea pedis), cutaneous candidiasis, pityriasis versicolor. • Topical Antibacterials: Impetigo, folliculitis, infected eczema/wounds, nasal MRSA decolonisation (Mupirocin)..
4. Therapeutic Indications & Evidence-Supported Uses
- • Topical Corticosteroids: Eczema / atopic dermatitis, contact dermatitis, plaque psoriasis, lichen planus, seborrhoeic dermatitis
- • Pure Topical Antifungals: Dermatophytosis (Tinea corporis, Tinea cruris [dhobi itch], Tinea pedis), cutaneous candidiasis, pityriasis versicolor
- • Topical Antibacterials: Impetigo, folliculitis, infected eczema/wounds, nasal MRSA decolonisation (Mupirocin)
🇮🇳 Jurisdiction & Indication Note: Indications and schedules reflect Indian compendial and regulatory records (CDSCO / Indian Pharmacopoeia & NFI / NLEM 2022). Where international reference labels (US FDA DailyMed / NCBI StatPearls) are cited for pharmacokinetic or mechanistic parameters, international approvals do not automatically imply CDSCO approval in India.
5. Educational Dosage Context, Formulations & Administration
Educational Dosing & Regimen Summary: General Adult Reference: Quantified by the Finger-Tip Unit (FTU)! 1 FTU (the ribbon of cream/ointment squeezed from a standard 5 mm nozzle along the adult index fingertip from the tip to the first distal crease) equals 0.5 grams and covers an area equal to 2 adult flat palms (with fingers together). • Topical Steroids: Apply a thin film once or twice daily for 1 to 2 weeks (up to 4 weeks on thick palms/soles). • Pure Antifungals: Apply to the lesion AND a 2 cm normal-looking border around the rash once daily (Luliconazole/Terbinafine) or twice daily (Clotrimazole/Sertaconazole) for at least 2 weeks AFTER the rash completely disappears (total 4 to 6 weeks)!
Administration & Meal Timing: External topical application only after washing and gently drying affected skin; wash hands before and after application (unless treating hands). Separate steroid cream and bland emollient by 20–30 minutes. | Once or twice daily after bathing and drying the skin thoroughly.
6. Pharmacokinetics, Metabolism & Renal/Hepatic Adjustment
Absorption, distribution, metabolism, and excretion follow class pharmacokinetic profile; verify patient renal/hepatic function.
Renal & Hepatic: No adjustment required for standard localised topical use. Caution: Applying >50 g/week of super-potent Clobetasol 0.05% over extensive denuded skin or under occlusion causes percutaneous systemic absorption, HPA-axis adrenal suppression, and iatrogenic Cushing's syndrome.
Renal & Hepatic: No adjustment required for standard localised topical use. Caution: Applying >50 g/week of super-potent Clobetasol 0.05% over extensive denuded skin or under occlusion causes percutaneous systemic absorption, HPA-axis adrenal suppression, and iatrogenic Cushing's syndrome.
Renal & Hepatic: No adjustment required for standard localised topical use. Caution: Applying >50 g/week of super-potent Clobetasol 0.05% over extensive denuded skin or under occlusion causes percutaneous systemic absorption, HPA-axis adrenal suppression, and iatrogenic Cushing's syndrome.
7. Contraindications, Precautions & High-Risk Warnings
- 1. THE EPIDEMIC INDIAN 'RINGWORM STEROID-COMBINATION' DISASTER (STRICT PHARMACIST BAN!): Across India, irrational fixed-dose triple/quadruple skin tubes combining a Super-Potent Steroid (Clobetasol) + Antifungal + Antibacterial (such as Panderm+, Quadriderm, Fourderm, Castor NF, Lobate-GM, Betnovate-C/N) are widely abused for fungal ringworm (Tinea cruris/corporis) and as fairness creams! Applying Clobetasol or Betnovate to a fungal infection suppresses local skin immunity—causing initial 2-day itch relief followed by explosive, treatment-resistant fungal spread ('Tinea Incognito'), irreversible purple skin striae (stretch marks), skin atrophy, telangiectasia, steroid rosacea, and HPA-axis Cushing's syndrome! NEVER dispense a steroid-containing cream for fungal ringworm, groin itch, acne, or facial fairness! 2. Never apply potent steroids (Clobetasol, Betamethasone) to the face, eyelids (causes glaucoma/cataracts!), axilla, or groin/genitalia!
Key Clinical Precautions: Renal & Hepatic: No adjustment required for standard localised topical use. Caution: Applying >50 g/week of super-potent Clobetasol 0.05% over extensive denuded skin or under occlusion causes percutaneous systemic absorption, HPA-axis adrenal suppression, and iatrogenic Cushing's syndrome.
8. Adverse Effects Profile
- Local transient stinging or burning; with prolonged/potent steroid misuse: skin thinning (epidermal atrophy), striae distensae, hypopigmentation, hypertrichosis, acneiform eruptions, perioral dermatitis.
- Systemic hypothalamic-pituitary-adrenal (HPA) axis suppression and iatrogenic Cushing's syndrome (when >50 g/week of Clobetasol 0.05% is applied over large body surfaces or under occlusion), glaucoma/cataracts (from periocular steroid use), recalcitrant steroid-modified dermatophytosis.
- Monitor for severe hypersensitivity, organ toxicity, or dose-limiting adverse events.
9. Major Drug–Drug, Drug–Food & Drug–Herb Interactions
- Minimal systemic drug interactions unless large-surface super-potent steroids are absorbed
10. Clinical Monitoring, Patient Counselling & Storage
Clinical & Laboratory Monitoring: Monitor clinical response, baseline renal/hepatic parameters, and relevant serum biomarkers.
Pharmacist Patient Counselling Points:
- Patient Counselling Checklist: 1. Enforce the '2-cm Margin & 2-Week Extra' Rule for Fungal Creams (Lulifin/Candid): Tell patients with groin/body ringworm to apply pure antifungal cream 2 cm beyond the red border and keep applying for 2 full weeks after the skin looks clear, while boiling/sun-drying cotton innerwear and avoiding tight damp clothes. 2. Demonstrate the Finger-Tip Unit (FTU) for steroid creams so patients apply a thin sheen rather than rubbing in half a tube. 3. If both a steroid cream and an emollient/moisturiser (liquid paraffin/white soft paraffin) are prescribed for eczema, wait 20–30 minutes between applying the steroid and the moisturiser. 4. For Permethrin 5% Cream (Perlice / Scabper for Scabies): Apply from the chin/jawline down to the soles of the feet (including webs between fingers/toes, wrists, navel, and groin), leave on overnight for 8 to 14 hours, wash off in the morning, treat all close family members simultaneously, wash bedsheets in hot water, and repeat a 2nd application exactly 7 days later! Explain that mild 'post-scabietic itching' can persist for 1–2 weeks after the mites are dead and does not mean treatment failed.
- Meal & Clock Timing Instruction: External topical application only after washing and gently drying affected skin; wash hands before and after application (unless treating hands). Separate steroid cream and bland emollient by 20–30 minutes. (Once or twice daily after bathing and drying the skin thoroughly.)
- Missed Dose Protocol: Apply as soon as remembered; do not apply double thickness.
- Geriatric Dispensing Pearl: Elderly CGHS patients have thin, fragile, xerotic (dry) senile skin with an impaired epidermal barrier—applying potent steroids (Tenovate/Betnovate) rapidly causes senile purpura, skin tearing, and ulceration. Encourage generous daily application of bland emollients (white soft paraffin + liquid paraffin) immediately after bathing while skin is damp.
Storage, Stability & Dispensing Safeguards: Store below 25°C–30°C in original moisture- and light-resistant packaging out of reach of children. Available forms: Creams (water-miscible base for weeping/acute/intertriginous lesions), Ointments (occlusive greasy base for dry, thick, lichenified plaques on palms/soles/extensors), Lotions/Solutions (for hairy scalp)
11. Visual Pharmacology & Mechanism Diagram (svg-v339-01-adme-12-step-journey)
12. Authoritative References, Regulatory Sources & Editorial Disclaimer
Primary Compendial & Guideline Reference: Indian Pharmacist Desk Reference — Professional Edition 2.7 (2026–27) • Ch 12 [12.6] (p. 157)
Official Verification Portals: Indian Pharmacopoeia Commission (IPC) & National Formulary of India (NFI) • Central Drugs Standard Control Organization (CDSCO) • Ministry of Health & Family Welfare — NLEM 2022 • NCBI Bookshelf / StatPearls Pharmacology Reference • DailyMed (US FDA Official Prescribing Reference)
Last Medically & Pharmaceutically Reviewed: 2026-11-10 • Verification Status: HANDBOOK_SOURCE_CONTENT
Educational & Clinical Disclaimer: This reference profile is published solely for pharmacy education, academic study, and professional clinical reference. It does not substitute for patient-specific clinical judgement, qualified specialist oncology/medical supervision, or official CDSCO/IP prescribing information. Never self-medicate with prescription, Schedule H/H1/X, NDPS, or oncology medicines.
13. Related Reference Monographs, Educational Guides & Visual Concept
💊 Related Pharmacological / Category Profiles
- [12.23] Permethrin (5% Scabicide Cream & 1% Pediculicide Lotion) — Topical Synthetic Pyrethroid Ectoparasiticide (Scabicide & Pedicu
- [12.24] Mupirocin (2% Topical & Intranasal MRSA Eradication Ointment) — Topical Pseudomonic Acid Antibiotic (Bacterial Isoleucyl-tRNA Syn
- [12.25] Clotrimazole (1% Topical Antifungal & 100/500 mg Vaginal Pessary) — Topical Imidazole Broad-Spectrum Antifungal (Ergosterol Synthesis
- [12.26] Betamethasone Valerate & Clobetasol Propionate (Topical Steroids) — Potent (Class II/III) Fluorinated Topical Corticosteroid